ADGRL3 and cancer: The deficiency in G protein signaling and cell motility reported here for these GAIN domain variants in Lphn3, and the report of cancer-related mutations in other aGPCRs targeting the same region, allude to a similar yet distinct function of this autoproteolysis-prone structural domain.